Investors

Insider Transactions

Date Name Title Sorted Ascending Type Shares Traded Price Range
Apr 1, 2013 goldstein joseph l Director Automatic Sell 5,000 180.00
Nov 6, 2013 goldstein joseph l Director Sell 1,000 300.74
Aug 14, 2013 goldstein joseph l Director Acquisition (Non Open Market) 5,000 n/a
Aug 23, 2013 goldstein joseph l Director Sell 1,000 238.29
Feb 12, 2014 goldstein joseph l Director Sell 1,000 320.62
Aug 14, 2014 goldstein joseph l Director Sell 2,000 347.65
Feb 20, 2014 goldstein joseph l Director Sell 1,000 326.96 - 327.17
Aug 6, 2014 goldstein joseph l Director Sell 2,000 331.20
Mar 25, 2014 goldstein joseph l Director Acquisition (Non Open Market) 10,000 n/a
Feb 25, 2014 goldstein joseph l Director Sell 1,000 338.86
Feb 14, 2012 goldstein joseph l Director Automatic Sell 15,000 110.02
Jan 19, 2012 goldstein joseph l Director Automatic Sell 10,000 80.00
Jan 10, 2012 goldstein joseph l Director Automatic Sell 20,000 74.35 - 75.00
Mar 15, 2012 goldstein joseph l Director Automatic Sell 10,000 110.77 - 115.00
Mar 26, 2012 goldstein joseph l Director Automatic Sell 5,000 120.00
Jan 4, 2013 goldstein joseph l Director Automatic Sell 5,000 180.50 - 181.22
Jan 9, 2013 goldstein joseph l Director Automatic Sell 5,000 185.00
Mar 21, 2011 goldstein joseph l Director Automatic Sell 11,505 40.00
Jul 1, 2011 goldstein joseph l Director Automatic Sell 10,000 55.91 - 56.40
Mar 9, 2011 goldstein joseph l Director Automatic Sell 3,495 39.35
Showing 241-260 of 1021 transactions Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52  See Previous 20 | See Next 20

Stock transaction information provided by EDGAR Online. Regeneron Pharmaceuticals, Inc. makes no representation or warranty with respect to any of the information contained herein, takes no responsibility for supplementing, updating or correcting any such information and shall have no liability with respect to any such information. This listing does not include derivatives, such as stock option grants or shares purchased through an employee stock purchase plan. For recent transactions, including derivative transactions, see our Section 16 SEC filings page.



Close
Form content here please :)